Darktrace And Endace Strike New Partnership To Combine Cyber AI And Forensics
Darktrace AI Integrates with EndaceProbe Analytics Platforms for Rapid Investigation with Definitive Forensic Evidence
SAN FRANCISCO and CAMBRIDGE, UK - October 16, 2018 (Investorideas.com Newswire) Darktrace and Endace today announced a partnership that combines Darktrace's cyber AI with Endace's unparalleled forensic capabilities. This combined solution empowers organizations to discover in-progress attacks anywhere on the digital infrastructure with Darktrace's AI, and investigate them with industry-leading speed, scale and accuracy using Endace's packet-level network history.
The EndaceProbe Analytics Platform arms organizations with the ability to record network traffic and conduct in-depth investigations by rapidly searching across petabytes of data for packets of interest. In addition to hosting Darktrace's Enterprise Immune System on the same hardware platform, organizations can now also host a wide range of security and performance monitoring analytics solutions, including other Endace Fusion Partner offerings, open-source or custom applications.
The world leader in cyber AI, Darktrace's Enterprise Immune System learns the ‘pattern of life' for every device and user across the digital infrastructure, and uses this evolving understanding of ‘normal' to detect and respond to emerging cyber-threats in real time.
"Organizations are facing an increasing barrage of both fast and stealthy cyber-attacks," said Justin Fier, Director of Cyber Intelligence and Analysis at Darktrace. "With Darktrace's Enterprise Immune System technology and EndaceProbe's network recording and hosting, our mutual customers can now easily benefit from both AI-powered cyber defense and the highest quality of forensic data, as they battle to protect their data and systems."
"The integration with Darktrace enables organizations to deploy cyber AI defense wherever they have an EndaceProbe," said Stuart Wilson, Endace CEO. "It gives IT teams definitive, packet-level evidence that lets them take decisive action in response to early-stage cyber-threats revealed by Darktrace, putting defenders back on the offensive and enabling them to stay ahead of cyber-threats."
The combined solution is available immediately. Contact Endace (firstname.lastname@example.org) or Darktrace (email@example.com) for a demo. More information on the partnership and related products can be found at www.endace.com/darktrace.
Endace's multifunctional Analytics Platform can host 3rd-party network analytics applications while simultaneously recording a 100% accurate Network History, providing definitive evidence for investigating cybersecurity threats, quantifying data breaches and analyzing network or application performance problems.
Deploying a dedicated Analytics Platform enables agile deployment of analytics functions on-demand and dramatically reduces OPEX and CAPEX costs by consolidating datacenter hardware. Hosted analytics applications can analyse live traffic at full line rate, or use Playback to analyse historical traffic for powerful, back-in-time analysis.Global customers include banks, hospitals, telcos, broadcasters, retailers, web giants, governments and military. www.endace.com
Darktrace is the world's leading AI company for cyber security. Created by mathematicians, the Enterprise Immune System uses machine learning and AI algorithms to detect and respond to cyber-threats across diverse digital environments, including cloud and virtualized networks, IoT and industrial control systems. The technology is self-learning and requires no set-up, identifying threats in real time, including zero-days, insiders and stealthy, silent attackers. Darktrace is headquartered in San Francisco and Cambridge, UK, and has 33 offices worldwide. www.darktrace.com.
Kelly Dorsey (US)
mobile +1-818-436 9646
Mark Evans (Australiasia)
mobile +64-21-494 850
Highwire PR (US)
+1 916 834 0802
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.